4Molina R, Filella X, Auge JM, et al. Tumor markers ( cea, ca 125, cyfra 21-1 ,scc and nse) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors[ J]. Tumour Biol, 2003,24 : 209. 被引量：1
5Pastor A, Menendez R, Cremades M.I, et al. Diagnostic value of scc, cea and cyfra 21.1 in lung cancer: A bayesian analysis[J]. Eur Respir J, 1997,10:603. 被引量：1
6Maeda T, Ueoka H, Tabata M, et al. Prognostic factors in advanced nonsmall cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis[ J]. Jpn J Clin Oncol, 2000,30: 534. 被引量：1
7Kulpa J, Wojcik E, Reinfuss M, et al. Carcinoembryonic antigen, squamous cell carcinoma antigen, cyfra 21-1, and neuron-specific enolase in squamous cell lung cancer patients[J]. Clin Chem,2002,48:1931. 被引量：1
8Wieskopf B, Demangeat C, Purohit A, et al. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role[J]. Chest, 1995,108 : 163. 被引量：1
9Ingebrlgtson T, Romner B. Biochemical Serum Markers of Traumatic Brain Injury. J Trmma 2002;52:798-808. 被引量：1
10Orlino EN Jr. Olmstead CE. Lazareff JA, Peacock WJ, Fisher RS, Fluharty AL. An enzyme immunoassay for neuron-specific enolase in cerebrospinal flud. Biochem Mol Mol 1997;60:41-46. 被引量：1
